Promise of mGluR2/3 activators in psychiatry
نویسندگان
چکیده
منابع مشابه
Forensic psychiatry, its place and its promise.
Forensic psychiatrists have always experienced problems when testifying before the bar of justice-some burdensome, some answered relatively easily. Indeed their position in court was ill defined until Benjamin Rush ( 18 12) and Isaac Ray (1 838) placed psychiatry on a more credible basis. After Ray solidified the field testifying was largely in the hands of Superintendents of Insane Asylums fro...
متن کاملThe Challenges and Promise of Neuroimaging in Psychiatry
Neuroimaging is central to the quest for a biological foundation of psychiatric diagnosis but so far has not yielded clinically relevant biomarkers for mental disorders. This review addresses potential reasons for this limitation and discusses refinements of paradigms and analytic techniques that may yield improved diagnostic and prognostic accuracy. Neuroimaging can also be used to probe genet...
متن کاملGlucokinase activators (GKAs) promise a new pharmacotherapy for diabetics
The glucose-phosphorylating enzyme glucokinase, a promising target for developing new antidiabetic agents, was identified through the combined efforts of basic research and human biochemical genetics. Allosteric glucokinase activators (GKAs) were discovered by high-throughput screening of a large compound library and first reported in 2003. GKAs stimulate insulin release and glucose metabolism ...
متن کاملHistory of Contemporary Cultural Psychiatry in Iran:
Cultural psychiatry is one of the relatively new trends in psychiatry that has received much attention today. During the last century, many Iranian psychiatrists have taken steps to introduce various aspects of cultural psychiatry from the field of epidemiology to the cultural conceptualization of psychiatric disorders. This article tries to refer to the history of contemporary cultural psychia...
متن کاملPharmacogenomics approach in psychiatry disorders
Psychiatric disorders are important health issues in the world, and their management is facing some serious challenges. Drugs that are widely used in the treatment of psychiatric disorders, including antidepressants, antipsychotics, and mood stabilizers, are often associated with many side effects and are adequately effective only in a small proportion of patients. Many factors, including genet...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuropsychopharmacology
سال: 2008
ISSN: 0893-133X,1740-634X
DOI: 10.1038/npp.2008.156